App-Ray vs ImmuniWeb® MobileSuite: 2026 Comparison
App-Ray is a free mobile app security tool. ImmuniWeb® MobileSuite is a commercial mobile app security tool by ImmuniWeb. Compare features, ratings, integrations, and community reviews side by side to find the best mobile app security fit for your security stack.
CST VerdictBased on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
Mobile app security teams responsible for iOS and Android compliance will find App-Ray's value in static analysis that flags OWASP Mobile Top 10 risks before apps hit production, avoiding costly post-release remediations. The free tier removes budget friction for mid-market shops running security on tight headcount; you get vulnerability scanning and basic compliance reporting without per-seat licensing. Skip App-Ray if your threat model centers on runtime behavior or if you need SAST integrated with your CI/CD pipeline; it's primarily a standalone scanning tool for developers and security reviewers who can run analysis between builds.
Development and security teams shipping native iOS and Android apps need ImmuniWeb® MobileSuite because its zero-false-positives SLA actually holds; you get manual penetration testing paired with AI automation, which means fewer alert binges and faster remediation cycles than pure-automation competitors. The vendor guarantees rapid delivery timelines and maintains NIST ID.RA risk assessment coverage, so you're not just scanning,you're getting structured evidence for compliance audits and board reporting. Skip this if your priority is backend infrastructure scanning alone; MobileSuite's strength is the mobile-first assessment, not API or cloud workload testing.
